CRISPR could potentially engineer super crops, make designer animal models for research and even snip out genetic diseases. Experts say that billions of dollars are at stake. But the landmark technology is embroiled in a legal battle over who controls the patent on CRISPR.
The latest episode of Speaking of Chemistry highlights everything you need to know about biotech's biggest patent case.Watch it here:
LEARN MORE: How Does CRISPR Gene-Editing Work?
This article has been republished from materials provided by The American Chemical Society.Note: material may have been edited for length and content. For further information, please contact the cited source.
